Showing results (431-440 of 757) with videos related to

Sort By:
Pageof 76
Clinical Kidney Journal|November 2, 2023
Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA)Pantelis Sarafidis, Fotini Iatridi, Charles Ferro, et al.
The American Journal of Case Reports|April 19, 2022
A 55-Year-Old Man with Recurrent Gastrointestinal Bleeding Due to Stricture of the Portal Vein Anastomotic Site 12 Years After Combined Pancreas and Kidney TransplantationSteffen Rassow, Stefan Büttner, Axel Thalhammer, et al.
American Journal of Hypertension|May 6, 2020
Empagliflozin for Patients With Presumed Resistant Hypertension: A Post Hoc Analysis of the EMPA-REG OUTCOME TrialJoão Pedro Ferreira, David Fitchett, Anne Pernille Ofstad, et al.
Clinical Kidney Journal|August 8, 2015
High convection volume in online post-dilution haemodiafiltration: relevance, safety and costsIra M Mostovaya, Muriel P C Grooteman, Carlo Basile, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 26, 2018
Value of the CHA2DS2-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillationDan Liu, Kai Hu, Marie Schmidt, et al.
European Heart Journal|December 6, 2012
Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patientsChristiane Drechsler, Eberhard Ritz, Andreas Tomaschitz, et al.
The New England Journal of Medicine|June 15, 2016
Empagliflozin and Progression of Kidney Disease in Type 2 DiabetesChristoph Wanner, Silvio E Inzucchi, John M Lachin, et al.
Atherosclerosis. Supplements|November 4, 2017
CaRe high - Cascade screening and registry for high cholesterol in GermanyNina Schmidt, Tanja Grammer, Ioanna Gouni-Berthold, et al.
ESC Heart Failure|June 16, 2021
Time to cardiovascular benefits of empagliflozin: a post hoc observation from the EMPA-REG OUTCOME trialSubodh Verma, Lawrence A Leiter, Bernard Zinman, et al.
The American Journal of Medicine|July 9, 2010
Department-related tasks and organ-targeted therapy in Fabry disease: an interdisciplinary challengeFrank Weidemann, Claudia Sommer, Thomas Duning, et al.
Pageof 76